Array Technologies, Inc.ARRY
| Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 |
|---|
| Net income (loss) | 59 | -50 | 4 | 137 |
|---|
| Provision for (recovery of) bad debts | 1 | -0 | 3 | 3 |
|---|
| Deferred tax benefit | -3 | -10 | -32 | -9 |
|---|
| Depreciation and amortization | 27 | 26 | 101 | - |
|---|
| Depreciation and amortization | - | - | - | 40 |
|---|
| Amortization of debt discount and issuance costs | 3 | 15 | 7 | 11 |
|---|
| Cost, Amortization | - | - | - | 15 |
|---|
| Interest paid-in-kind | 3 | - | - | - |
|---|
| Amortization of debt discount and issuance costs | 3 | 15 | 7 | 11 |
|---|
| Equity-based compensation | 5 | 14 | 15 | 15 |
|---|
| Gain on debt refinancing | - | - | - | 0 |
|---|
| Contingent consideration | 26 | 3 | -5 | 3 |
|---|
| Equity-based compensation | 5 | 14 | 15 | 15 |
|---|
| Warranty provision | - | 1 | 4 | - |
|---|
| Contingent consideration | 26 | 3 | -5 | 3 |
|---|
| Inventory Write-down | 1 | 1 | -1 | 6 |
|---|
| Warranty provision | 1 | - | - | 5 |
|---|
| Inventory Write-down | 1 | 1 | -1 | 6 |
|---|
| Accounts receivable | 23 | 117 | 77 | -93 |
|---|
| Inventories | -28 | 88 | -21 | -67 |
|---|
| Income tax receivables | 17 | -8 | -6 | -0 |
|---|
| Prepaid expenses and other | -1 | 21 | -19 | 11 |
|---|
| Accounts payable | -51 | 9 | 13 | -38 |
|---|
| Accrued expenses and other | 11 | 9 | 1 | 5 |
|---|
| Income tax payable | 7 | -9 | -1 | 2 |
|---|
| Lease liabilities | - | 0 | 4 | 1 |
|---|
| Contingent consideration | 25 | - | - | - |
|---|
| Deferred revenue | -179 | -51 | 59 | -112 |
|---|
| Deferred revenue | -179 | -51 | 59 | -112 |
|---|
| Net cash provided by (used in) operating activities | -122 | -263 | 141 | 232 |
|---|
| Net cash provided by (used in) operating activities | -122 | -263 | 141 | 232 |
|---|
| Purchase of property, plant and equipment | 1 | 3 | 11 | 17 |
|---|
| Acquisition of STI, net of cash acquired | - | - | 374 | - |
|---|
| Retirement/disposal of PP&E | - | - | - | 0 |
|---|
| Investment in equity security | - | 12 | - | - |
|---|
| Acquisition of STI, net of cash acquired | - | - | 374 | - |
|---|
| Net cash used in investing activities | -1 | -15 | -384 | -17 |
|---|
| Net cash used in investing activities | -1 | -15 | -384 | -17 |
|---|
| Proceeds from Series A issuance | - | 225 | 33 | - |
|---|
| Proceeds from common stock issuance | - | 121 | 16 | - |
|---|
| Series A equity issuance costs and commitment fees | - | 7 | 2 | 2 |
|---|
| Common stock issuance costs | - | 4 | 0 | - |
|---|
| Dividends paid on Series A Preferred | - | 8 | 19 | - |
|---|
| Payments on revolving credit facility | - | 126 | 116 | - |
|---|
| Proceeds from Lines of Credit | - | 126 | 116 | - |
|---|
| Proceeds from Other Debt | - | - | 20 | 63 |
|---|
| Proceeds from issuance of convertible notes | - | 413 | - | - |
|---|
| Premium paid on capped call | - | 53 | - | - |
|---|
| Fees paid on issuance of convertible notes | - | 2 | - | - |
|---|
| Principal payments on term loan facility | 58 | - | 14 | 74 |
|---|
| Proceeds from term loan facility | 575 | - | - | - |
|---|
| Principal payments on other debt | - | - | 24 | 88 |
|---|
| Principal payments on other debt | - | - | 24 | 88 |
|---|
| Contingent consideration payments | - | 8 | 1 | 1 |
|---|
| Payments on related party loans | 46 | - | - | - |
|---|
| Debt issuance costs | 36 | 7 | - | - |
|---|
| Payment of special distribution | 589 | - | - | - |
|---|
| Net cash (used in) provided by financing activities | -129 | 538 | 8 | -102 |
|---|
| Contingent consideration payments | - | 8 | 1 | 1 |
|---|
| Deferred offering costs | 6 | - | - | - |
|---|
| Debt issuance costs | 36 | 7 | - | - |
|---|
| Net cash (used in) provided by financing activities | -129 | 538 | 8 | -102 |
|---|
| Effect of exchange rate changes on cash and cash equivalent balances | - | - | 1 | 2 |
|---|
| Net change in cash and cash equivalents | -253 | 259 | -234 | 115 |
|---|
| Cash paid for interest | 7 | 24 | 23 | 44 |
|---|
| Income Taxes Paid, Net | 31 | 13 | 11 | 46 |
|---|
| Dividends, Preferred Stock, Stock | - | - | 6 | 26 |
|---|
| Stock consideration paid for acquisition of STI | - | - | 200 | - |
|---|